MDT

95.73

+0.22%↑

VEEV

287.15

+0.07%↑

A

139.05

+1.82%↑

HQY

93.1

+2.79%↑

PHR.US

22.07

-1.12%↓

MDT

95.73

+0.22%↑

VEEV

287.15

+0.07%↑

A

139.05

+1.82%↑

HQY

93.1

+2.79%↑

PHR.US

22.07

-1.12%↓

MDT

95.73

+0.22%↑

VEEV

287.15

+0.07%↑

A

139.05

+1.82%↑

HQY

93.1

+2.79%↑

PHR.US

22.07

-1.12%↓

MDT

95.73

+0.22%↑

VEEV

287.15

+0.07%↑

A

139.05

+1.82%↑

HQY

93.1

+2.79%↑

PHR.US

22.07

-1.12%↓

MDT

95.73

+0.22%↑

VEEV

287.15

+0.07%↑

A

139.05

+1.82%↑

HQY

93.1

+2.79%↑

PHR.US

22.07

-1.12%↓

Search

Revvity Inc

Open

BrancheGesundheitswesen

91.04 2.82

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

88.08

Max

91.2

Schlüsselkennzahlen

By Trading Economics

Einkommen

14M

55M

Verkäufe

56M

720M

KGV

Branchendurchschnitt

40.6

37.257

EPS

1.18

Dividendenrendite

0.3

Gewinnspanne

7.667

Angestellte

11,000

EBITDA

22M

194M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+24.02% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.30%

2.94%

Nächstes Ergebnis

27. Okt. 2025

Nächste Dividendenausschüttung

7. Nov. 2025

Nächstes Ex-Dividendendatum

17. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

146M

11B

Vorheriger Eröffnungskurs

88.22

Vorheriger Schlusskurs

91.04

Nachrichtenstimmung

By Acuity

49%

51%

154 / 371 Ranking in Healthcare

Revvity Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Okt. 2025, 21:50 UTC

Akquisitionen, Fusionen, Übernahmen

Caterpillar to Acquire Australia's RPM Global for $730 Million

10. Okt. 2025, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Strathcona Resources Terminates Take-Over Bid for MEG Energy

12. Okt. 2025, 23:47 UTC

Market Talk

Gold Rises, Buoyed by Monetary Debasement Fears -- Market Talk

12. Okt. 2025, 23:39 UTC

Market Talk

Oil Rises on Likely Technical Recovery, Mildly Positive Sentiment -- Market Talk

12. Okt. 2025, 23:22 UTC

Market Talk

New Zealand Braces For Renewed Trade War Uncertainty -- Market Talk

12. Okt. 2025, 23:16 UTC

Akquisitionen, Fusionen, Übernahmen

Caterpillar Inc. Enters Into Agreement To Acquire RPMGlobal >CAT RUL.AU

12. Okt. 2025, 22:32 UTC

Market Talk

Copper, U.S. Thermal Coal Stand Out as Metals Ride Macro Tailwinds -- Market Talk

12. Okt. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

RPM Global Says Board Unanimously Recommends Shareholders Accept Caterpillar Offer

12. Okt. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

RPM Global Agrees to Takeover by Caterpillar

12. Okt. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

RPM Global Says Caterpillar Offering A$5.00/Share in Cash

11. Okt. 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

11. Okt. 2025, 00:18 UTC

Akquisitionen, Fusionen, Übernahmen

Why Biotech May Be Back -- Barrons.com

10. Okt. 2025, 21:07 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Dell Is Just Beginning to Tell Its AI Story. Buy the Stock. -- Barrons.com

10. Okt. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Okt. 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

10. Okt. 2025, 20:06 UTC

Market Talk

Fed Won't Publish Monthly Industrial Data Next Week -- Market Talk

10. Okt. 2025, 20:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Okt. 2025, 19:56 UTC

Market Talk

U.S.-China Tension Weighs Down on Treasury Yields, Dollar -- Market Talk

10. Okt. 2025, 19:20 UTC

Market Talk

Oil Futures Sink As Trump Rekindles Trade Tensions -- Market Talk

10. Okt. 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

10. Okt. 2025, 18:58 UTC

Market Talk

Canada's Jobs Gain Marks a 'Head Fake' For Economy -- Market Talk

10. Okt. 2025, 18:52 UTC

Market Talk

PepsiCo Lays Groundwork for Improvement -- Market Talk

10. Okt. 2025, 18:47 UTC

Market Talk

Precious Metals Turn Higher After Profit-Taking Slide -- Market Talk

10. Okt. 2025, 18:35 UTC

Market Talk

Canada's Next Rate Cut May be Pushed to December -- Market Talk

10. Okt. 2025, 18:31 UTC

Market Talk

Canada's Labor Market Firming. But Conditions Vary Across Country -- Market Talk

10. Okt. 2025, 17:32 UTC

Market Talk

U.S. Oil Rig Count Declines by Four to 418 -- Market Talk

10. Okt. 2025, 16:55 UTC

Ergebnisse

These Stocks Are Moving the Most Today: MP Materials, Nvidia, Alibaba, Venture Global, Applied Digital, Qualcomm, and More -- Barrons.com

10. Okt. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

10. Okt. 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Revvity Inc Prognose

Kursziel

By TipRanks

24.02% Vorteil

12-Monats-Prognose

Durchschnitt 109.5 USD  24.02%

Hoch 129 USD

Tief 96 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Revvity Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

8

Buy

6

Halten

0

Sell

Stimmung

By Acuity

154 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat